DIOD PAO

DIOD PAO Cash Conversion

The Cash Conversion Rate (OCF/Net Income) of DIOD PAO (DIOD.ME) as of Nov 17, 2026 is 40.05 %. In the previous year, Cash Conversion Rate (OCF/Net Income) was 248.60 % — a change of -83.89% (lower).

Cash Conversion

40.05 %

YoY

-83.89%

Last updated:

Cash Conversion Rate (OCF/Net Income) of DIOD PAO is 2023 40.05 % . Cash Conversion Rate (OCF/Net Income) of DIOD PAO was 2022 248.60 % . It decreases by -83.89% lower compared to the previous year.

The DIOD PAO Cash Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion
Date
Cash Conversion
Jan 1, 2016
57.97 RUB
Jan 1, 2017
-412.76 RUB
Jan 1, 2018
480.41 RUB
Jan 1, 2019
264.71 RUB
Jan 1, 2020
239.87 RUB
Jan 1, 2021
114.41 RUB
Jan 1, 2022
248.60 RUB
Jan 1, 2023
40.05 RUB
The DIOD PAO Cash Conversion history
YEARCash ConversionYoY
40.05 %-83.89%
248.60 %+117.29%
114.41 %-52.31%
239.87 %-9.38%
264.71 %-44.90%
480.41 %-216.39%
-412.76 %-812.01%
57.97 %-166.79%
-86.79 %-194.39%
91.94 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

DIOD PAO Stock analysis

What does DIOD PAO do? DIOD PAO generates revenue through the manufacturing and sale of pharmaceuticals, dietary supplements, medical cosmetic products, and medical equipment. Its product portfolio includes iodine, selenium, and calcium-based vitamins, as well as silver water purifiers and light therapy apparatus. The company serves healthcare providers, consumers, and medical centers like Mir ekologii, which it owns, through its subsidiaries and affiliated companies. Revenue streams are derived from direct sales of these products and services to end-users and healthcare institutions. The company's main focus is on eco-friendly and natural-based products, targeting consumers seeking health and wellness solutions. Its subsidiaries and affiliated companies facilitate distribution across various segments, including pharmaceuticals, dietary supplements, and medical equipment. The firm's medical center Mir ekologii complements its product offerings by providing healthcare services that align with its natural health focus. DIOD PAO's revenue model relies on the production and sale of its branded products, such as iodine, selenium, and calcium-based vitamins, which are sold through its subsidiaries. The medical equipment segment, including silver water purifiers and light therapy apparatus, contributes to its revenue through direct consumer and institutional sales. The ownership of Mir ekologii allows the company to integrate healthcare services with its product portfolio, enhancing customer retention and cross-selling opportunities. DIOD PAO is one of the most popular companies on Eulerpool.

Frequently Asked Questions about DIOD PAO stock

Cash Conversion Rate (OCF/Net Income) of DIOD PAO is 40.05 % in 2023.

Cash Conversion Rate (OCF/Net Income) of DIOD PAO changed from 248.60 % to 40.05 %, representing a -83.89% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Rate (OCF/Net Income) DIOD PAO since 2006 – with annual values, charts, and detailed analysis.

Cash conversion measures how effectively net income converts to operating cash flow. Ratios above 100% indicate high-quality, cash-backed earnings.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Rate (OCF/Net Income)'s DIOD PAO with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Rate (OCF/Net Income)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Rate (OCF/Net Income).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — DIOD PAO

All Key Metrics — DIOD PAO